Abstract
The process of clinical development of a new drug has so far involved the general practitioner (GP) only to a very marginal extent. Obvious safety reasons and, at least in Italy, the law prevent the GP from taking a direct part in the first phases of clinical research; on the other hand, even after the introduction of a medicine onto the market, the general practitioner’s involvement is considered to be that of prescription rather than evaluation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Basagni M, Baroni L, Lucchelli PE (1977) Diagnostic policies of minor depressive illness by two differently trained groups of general practitioners. Int.1 Clin Pharmacol 15: 474–476
Canti D, Lucchelli PE (1971) Effects of Glyvenol in relation to the dosage schedule employed (results of a large-scale trial in general practice). In: Kappert A (ed) Current aspects of chronic venous insufficiency. Ciba Geigy, Basel, p 186–200
Haines RB (1976) Strategies for improving compliances: a methodologic analysis and review. In: Sackett DL and Haines RB (eds) Compliance with Therapeutic Regimens. The Johns Hopkins University Press, Baltimore London, p 69–82
Lasagna L. This volume, P 45–49
Morris LA, Halperin JA (1979) Effects of written drug information on patient knowledge and compliance: a literature review. Am J Public Health 69: 47–52
Selvini A (1976) Depression: a psychoterapeutic approach. In: Cassano GB, Lucchelli PE (eds) Psychosomatics and depression in general practice. Pozzi, Roma, p 10–17
Wheatley D (1973) Clinical Evaluation and Use of Drugs in General Practice. In: Jouhar AJ, Grayson MF (eds) International Aspects of Drug Evaluation and Usage. Churchill Livingstone, Edinburgh London, p 301–308
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Lucchelli, P.E. (1985). Clinical trials and the general practitioner. In: Steichele, C., Abshagen, U., Koch-Weser, J. (eds) Drugs between Research and Regulations. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-642-54130-8_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-54130-8_8
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-642-54132-2
Online ISBN: 978-3-642-54130-8
eBook Packages: Springer Book Archive